The Removal of Human Breast Cancer Cells from Hematopoietic CD34+Stem Cells by Dielectrophoretic Field-Flow-Fractionation

Abstract

Dielectrophoretic field-flow-fractionation (DEP-FFF) was used to purge human breast cancer MDA435 cells from hematopoietic CD34⁺ stem cells. An array of interdigitated microelectrodes lining the bottom surface of a thin chamber was used to generate dielectrophoretic forces that levitated the cell mixture in a fluid flow profile. CD34⁺ stem cells were levitated higher, were carried faster by the fluid flow, and exited the separation chamber earlier than the cancer cells. Using on-line flow cytometry, efficient separation of the cell mixture was observed in less than 12 min, and CD34⁺ stem cell fractions with a purity > 99.2% were obtained. The method of DEP-FFF is potentially applicable to many biomedical cell separation problems, including microfluidic-scale diagnosis and preparative-scale purification of cell subpopulations.